We are live on ! Find out more
ICUI icon

ICU Medical

283 hedge funds and large institutions have $3.54B invested in ICU Medical in 2020 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 88 increasing their positions, 103 reducing their positions, and 46 closing their positions.

New
Increased
Maintained
Reduced
Closed

327% more call options, than puts

Call options by funds: $11.9M | Put options by funds: $2.8M

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

2% less capital invested

Capital invested by funds: $3.6B → $3.54B (-$58.7M)

1.21% less ownership

Funds ownership: 93.75%92.55% (-1.2%)

4% less funds holding

Funds holding: 294283 (-11)

15% less repeat investments, than reductions

Existing positions increased: 88 | Existing positions reduced: 103

22% less first-time investments, than exits

New positions opened: 36 | Existing positions closed: 46

Holders
283
Holders Change
-11
Holders Change %
-3.74%
% of All Funds
5.71%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
36
Increased
88
Reduced
103
Closed
46
Calls
$11.9M
Puts
$2.8M
Net Calls
+$9.14M
Net Calls Change
-$22.3M
Name Holding Trade Value Shares
Change
Change in
Stake
CGH
176
Crossmark Global Holdings
Texas
$398K -$24.5K -130 -6%
Zurich Cantonal Bank
177
Zurich Cantonal Bank
Switzerland
$389K +$59.9K +318 +18%
CAPTRUST Financial Advisors
178
CAPTRUST Financial Advisors
North Carolina
$379K -$6.97K -37 -2%
QIM
179
Quantitative Investment Management
Virginia
$358K -$225K -1,193 -38%
Mercer Global Advisors
180
Mercer Global Advisors
Colorado
$354K -$39.9K -212 -10%
AII
181
AGF Investments Inc
Ontario, Canada
$349K +$85.8K +456 +31%
MF
182
Magnetar Financial
Illinois
$348K +$7.15K +38 +2%
SAM
183
Securian Asset Management
Minnesota
$346K -$19.2K -102 -5%
PNC Financial Services Group
184
PNC Financial Services Group
Pennsylvania
$339K -$371K -1,973 -52%
ETC
185
Exchange Traded Concepts
Oklahoma
$338K +$91.7K +487 +36%
Walleye Trading
186
Walleye Trading
New York
$323K +$332K +1,765 New
TC
187
TwinBeech Capital
New York
$321K -$345K -1,830 -51%
Wolverine Trading
188
Wolverine Trading
Illinois
$315K +$50.3K +267 +18%
BBHC
189
Brown Brothers Harriman & Co
New York
$313K
PAMU
190
Pictet Asset Management (UK)
United Kingdom
$311K +$320K +1,700 New
PA
191
Profund Advisors
Maryland
$308K +$97.5K +518 +44%
JMPWA
192
JP Morgan Private Wealth Advisors
California
$304K -$134K -712 -30%
ProShare Advisors
193
ProShare Advisors
Maryland
$302K +$11.1K +59 +4%
Fidelity Investments
194
Fidelity Investments
Massachusetts
$277K -$3.39K -18 -1%
GCP
195
GSA Capital Partners
United Kingdom
$273K +$281K +1,495 New
RJT
196
Raymond James Trust
Florida
$263K -$44.6K -237 -14%
AA
197
ALPS Advisors
Colorado
$257K +$265K +1,407 New
LIA
198
LS Investment Advisors
Michigan
$242K
ACM
199
AlphaCrest Capital Management
New York
$239K +$246K +1,305 New
PSUF
200
People's United Financial
Connecticut
$224K -$613K -3,256 -73%

ICUI Hedge Fund Activity: Q3 2020 in Review

283 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in ICU Medical (ICUI) for Q3 2020, worth a combined $3.54B — down 1.6% from $3.6B a quarter earlier.

Sellers outnumbered buyers: 46 funds closed out of ICUI and 36 opened new positions — a net loss of 10 holders — while 103 trimmed existing stakes and 88 added.

The largest buyer was Janus Henderson Group, adding an estimated $58.1M. The largest seller was Eminence Capital, exiting entirely with an estimated $15.3M sold.

  • 283 institutional investors held ICU Medical (ICUI) as of Q3 2020, down from 294 in Q2 2020.
  • Funds reported $3.54B of ICU Medical stock for Q3 2020, down 1.6% quarter-over-quarter.
  • 36 funds opened new ICU Medical positions in Q3 2020 and 46 closed out, a net change of -10 holders.
  • The largest ICU Medical buyer in Q3 2020 was Janus Henderson Group, an estimated $58.1M added.
  • The largest ICU Medical seller in Q3 2020 was Eminence Capital, an estimated $15.3M sold.

Based on aggregated 13F filings for Q3 2020.